Human Normal Immunoglobulin & Anti-D Immunoglobulin
Human Normal Immunoglobulin and Anti-D Immunoglobulin: Period of framework agreement: 1 July 2021 to 31 December 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Buyer
NHS ENGLAND
Value
£450,000,000
Published
15 Jan 2021
Closes
15 Jan 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33651520
Immunoglobulins
Lots
Lot default Human Normal Immunoglobulin & Anti-D Immunoglobulin
£450,000,000
Human Normal Immunoglobulin and Anti-D Immunoglobulin: Period of framework agreement: 1 July 2021 to 31 December 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Delivery: British Oversea Territories, Channel Islands, England · United Kingdom, Europe, Guernsey, Isle of Man
Documents
Unlock document linkFuture opportunity notice on Contracts Finder
13 Dec 2019
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.